2d agoMarketWatchBULLISH 63General
Archived explainer. For the current picture see today's ELV page.
Why Is ELEVANCE HEALTH INC (ELV) Stock Up Today?
By the Top Tier Newswire AI Desk · September 11, 2026 at 12:14 AM ET · reviewed against 6 wire stories
ELEVANCE HEALTH INC (ELV) is up +5.41% in the latest session. Our newswire has captured 6 stories on ELV across 5 sources in the last 36 hours, with AI sentiment reading mixed (avg 55/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Elevance Health Inc. stock rose 5.41% to $416.54 on Tuesday, outperforming broader market trends amid a reaffirmation of its 2026 earnings and cost guidance. The move followed an 8-K filing by the company and appears to have been driven by positive investor reaction to its recent outlook and management activity.
What Happened
Elevance Health reaffirmed its 2026 earnings and cost guidance, which was disclosed in a Regulation FD filing on September 10. The company’s stock gained traction as the announcement reinforced confidence in its operational direction. Additionally, management is scheduled to meet with Oppenheimer, signaling ongoing engagement with key analysts and investors. Recent insider transactions also contributed to the positive sentiment, with CEO Gail Boudreaux and director Ramiro G. Peru purchasing shares on July 17. These actions, combined with the reaffirmed guidance, suggest continued internal confidence in the company’s trajectory.
What The Data Shows
Over the past eight trading sessions, ELV has gained 6.4%, rising from $393.30 to $418.58. The stock has printed two fresh 52-week highs on September 10, indicating sustained upward momentum. The company has a market cap of $87.2 billion, with a P/E ratio of 17.7 and trailing 12-month revenue growth of 6.3%. Its beta of 0.70 suggests it is less volatile than the broader market. Recent insider activity includes $1.4 million in purchases and $149,000 in sales over the past 90 days, with the most recent transactions occurring on July 17.
What To Watch
The company is set to meet with Oppenheimer, which could provide further clarity on its strategic direction and investor expectations. Traders should also monitor the breadth of coverage and any follow-up statements from analysts or management in the coming days.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
ELV by the numbers
Last: $416.54Session: +5.41%7 sessions: +4.41%Coverage: 6 stories / 5 sourcesAI sentiment: 55/100 (mixed)Mkt cap: $87.2BP/E: 17.752w: $274.84 to $436.24
The headlines behind the move
2d agoInvesting.com MarketsNEUTRAL 50General
Why is Elevance Health stock surging today?
Why is Elevance Health stock surging today?
3d agoTipRanksBULLISH 56Earnings
Elevance Health Reaffirms 2026 Earnings and Cost Guidance
An announcement from Elevance Health ( ($ELV) ) is now available. Elevance Health, Inc. is a U.S.-based health benefits company operating in the managed care and in...
3d agoSEC 8-KNEUTRAL 50General
Elevance Health, Inc. (ELV) files 8-K
Filed: 2026-09-10 AccNo: 0001156039-26-000063 Size: 175 KB Item 7.01: Regulation FD Disclosure
3d agoMarketWatchBULLISH 58General
Elevance Health Inc. stock outperforms competitors despite losses on the day
3d agoThe FlyBULLISH 55General
Elevance Health management to meet with Oppenheimer
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on ELV: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier ELV move explainers: 2026-09-11 · 2026-09-10